Package 0002-4184-30

Brand: evista

Generic: raloxifene hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0002-4184-30
Digits Only 0002418430
Product NDC 0002-4184
Description

30 TABLET in 1 BOTTLE (0002-4184-30)

Marketing

Marketing Status
Marketed Since 2016-12-16
Brand evista
Generic raloxifene hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d46edd04-2907-438c-9e1f-b94b5509c0fd", "openfda": {"upc": ["0300024184305"], "unii": ["4F86W47BR6"], "rxcui": ["1490065", "1490067"], "spl_set_id": ["fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0002-4184-30)", "package_ndc": "0002-4184-30", "marketing_start_date": "20161216"}], "brand_name": "Evista", "product_id": "0002-4184_d46edd04-2907-438c-9e1f-b94b5509c0fd", "dosage_form": "TABLET", "pharm_class": ["Estrogen Agonist/Antagonist [EPC]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "0002-4184", "generic_name": "Raloxifene hydrochloride", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Evista", "active_ingredients": [{"name": "RALOXIFENE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "NDA020815", "marketing_category": "NDA", "marketing_start_date": "19980106", "listing_expiration_date": "20261231"}